Philippe Moreau

Title: Philippe Moreau: Innovator in Cancer Treatment

Introduction

Philippe Moreau is a notable inventor based in Viry-Chatillon, France. He has made significant contributions to the field of cancer treatment through his innovative methods and research. With a total of 3 patents to his name, Moreau's work focuses on the selection and analysis of tumors expressing HLA-G.

Latest Patents

One of Moreau's latest patents is a method for selecting tumors that express HLA-G, which are sensitive to anticancer treatment. This invention aims to inhibit or prevent the HLA-G activity of such tumors. The method involves establishing the HLA-G transcription profile of a solid tumor by drawing a tumoral sample, extracting mRNA, and performing reverse transcription. It also includes the amplification of cDNA in the presence of specific primers and analyzing the resulting products. Another significant patent involves the transcripts of the MHC class I HLA-G gene, which are present in fetal trophoblasts and adult circulating mono-nuclear cells. These transcripts have various applications in understanding tumor behavior and treatment responses.

Career Highlights

Philippe Moreau is associated with the Commissariat à l'Énergie Atomique, where he continues to advance his research in cancer treatment. His work has been instrumental in developing methods that could potentially improve patient outcomes in oncology.

Collaborations

Moreau has collaborated with esteemed colleagues such as Edgardo Delfino Carosella and Eliane Gluckman. These partnerships have enriched his research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Philippe Moreau's innovative work in the field of cancer treatment highlights the importance of research and development in medical science. His patents and collaborations reflect a commitment to improving therapeutic strategies for cancer patients.